Log In
Print this Print this

Sustained-release travoprost (OTX-TP)

  Manage Alerts
Collapse Summary General Information
Company Ocular Therapeutix Inc.
DescriptionHydrogel-based punctum plug that delivers sustained-release travoprost over 90 days
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationGlaucoma
Indication DetailsTreat open-angle glaucoma or ocular hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today